Skip to main content
UAB - The University of Alabama at Birmingham
admin login frontend login
Neurofibromatosis Consortium
Heersink School of Medicine
  • UAB Quicklinks
      • UAB Home
      • Academic Calendar
      • Accessibility
      • AdminSystems
      • Apply
      • AskIT
      • Blazer Express
      • BlazerNET
      • BlazerPulse
      • Bookstore
      • Campus Calendar
      • Campus Map
      • Canvas
      • Departments
      • Directory
      • Email
      • Emergency/B-Alert
      • Employee Resources
      • Employment
      • MyUAB Employee Portal
      • Giving to UAB
      • TechConnect
      • UAB eLearning
      More Items
  • NF Consortium Quicklinks
    • NF Consortium Home
    • Children's Tumor Foundation
    • Neurofibromatosis, Inc.
    • UnderstandingNF1
    • ClinicalTrials.gov
 
  • Home
  • Consortium Sites
  • FAQ
  • Contact Us
  • Clinical Trials
    • NF101: STARS Study
    • NF102: STOPN Study
    • NF103: RAD001 (Everolimus) Study
    • NF104: NF2 (Bevacizumab) Study
    • NF105: Cabozantinib (XL184) Study
    • NF106: MEK Inhibitor Study (PD-0325901)
    • NF107: BMP-2 INFUSE Study
    • NF108: Binimetinib Study
    • NF110: Crizotinib Study
    • NF111: Low Grade Glioma Study (Poly-ICLC)
    • NF112: MPNST Study (In Development)
  • Publications

We're dedicated to conducting clinical trials to improve the quality of life of persons with neurofibromatosis.

Since the discovery of the genes responsible for the different forms of neurofibromatosis, much has been learned about how the various problems associated with neurofibromatosis come about. This opens the door towards development and testing of medications that may be helpful in preventing or treating complications of the disorders. The NF Clinical Trials Consortium was formed in 2006 with funding from the U.S. Army Medical Research and Materiel Command to carry out clinical trials of such medications. The Consortium consists of thirteen primary and ten affiliate clinical centers around the US and Australia with an Operations Center at the University of Alabama at Birmingham to coordinate consortium activities.

 
  • Contact UAB
  • |
  • |
  • A-Z Site Index
  • |
  • Privacy
  • |
  • Terms of Use
  • |
  • © 2023 The University of Alabama at Birmingham
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.